A rare presentation of probable catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage
- 1Department of General Medicine, Vivekananda Institute of Medical Sciences, Kolkata 700026, India.
- 2Department of Endocrinology, Vivekananda Institute of Medical Sciences, Kolkata 700026, India.
Abstract
Catastrophic antiphospholipid syndrome (APS), a rare thrombotic manifestation of APS, is associated with high mortality. Rarely, it can present with bilateral adrenal hemorrhage (BAH). This case highlights a rare presentation of BAH due to probable catastrophic APS secondary to systemic lupus erythematosus (SLE). A 57-year-old female with diabetes presented with hypovolemic shock, abdominal pain, and vomiting. Imaging revealed BAH; antiphospholipid antibodies were present in high titers in the blood. Antinuclear antibody and antidouble-stranded deoxyribonucleic acid antibody (anti-dsDNA) were positive in high titers. Catastrophic APS secondary to SLE was diagnosed. Serum morning cortisol was at 9.2 μg/dL (SI: 254 nmol/L) (reference range: 5-25 μg/dL [SI: 138-635 nmol/L]), and adrenocorticotropic hormone was at 180 pg/mL (SI: 39.6 pmol/L) (reference range: 10-60 pg/mL [SI: 1.6-13.9 pmol/L]); which indicated evolving primary adrenal insufficiency. The patient received pulse methylprednisolone, intravenous immunoglobulin, anticoagulants, and mycophenolate mofetil. Oral glucocorticoid was continued with regular monitoring of adrenal function. Mineralocorticoid replacement was not needed as the renin-angiotensin-aldosterone system axis was intact. This report contributes to the sparse literature on catastrophic APS-related BAH, highlighting the need for early diagnosis and combined immunosuppressive and anticoagulant treatment.
Related
- P022 Catastrophic antiphospholipid syndrome: early recognition of a rare and life threatening presentation
- P026 Catastrophic antiphospholipid syndrome occurring two months after a surgical herald event in a patient with quiescent systemic lupus erythematosus and stable antiphospholipid syndrome on therapeutic warfarin
- Case Report: Bilateral pes planovalgus: an uncommon pediatric orthopedic presentation of Charcot–Marie–Tooth disease type 4B1
- From Hemorrhage to Pyometra: A Complex Postpartum Cascade Following B-Lynch Suturing and Bilateral Internal Iliac Artery Ligation.
- Bilateral postpartum renal cortical necrosis complicated by peripartum cardiomyopathy after postpartum hemorrhage: a case report
BibTeX
@article{maji2026rare,
title = {{A rare presentation of probable catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage}},
author = {Jyotirmay Maji and Ajitesh Roy},
journal = {JCEM case reports},
year = {2026},
month = nov,
doi = {10.1210/jcemcr/luag345},
url = {https://europepmc.org/article/PMC/PMC13752508},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - A rare presentation of probable catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage
AU - Jyotirmay Maji
AU - Ajitesh Roy
PY - 2026
DA - 2026/11/11
JO - JCEM case reports
DO - 10.1210/jcemcr/luag345
UR - https://europepmc.org/article/PMC/PMC13752508
AB - Catastrophic antiphospholipid syndrome (APS), a rare thrombotic manifestation of APS, is associated with high mortality. Rarely, it can present with bilateral adrenal hemorrhage (BAH). This case highlights a rare presentation of BAH due to probable catastrophic APS secondary to systemic lupus erythematosus (SLE). A 57-year-old female with diabetes presented with hypovolemic shock, abdominal pain, and vomiting. Imaging revealed BAH; antiphospholipid antibodies were present in high titers in the blood. Antinuclear antibody and antidouble-stranded deoxyribonucleic acid antibody (anti-dsDNA) were positive in high titers. Catastrophic APS secondary to SLE was diagnosed. Serum morning cortisol was at 9.2 μg/dL (SI: 254 nmol/L) (reference range: 5-25 μg/dL [SI: 138-635 nmol/L]), and adrenocorticotropic hormone was at 180 pg/mL (SI: 39.6 pmol/L) (reference range: 10-60 pg/mL [SI: 1.6-13.9 pmol/L]); which indicated evolving primary adrenal insufficiency. The patient received pulse methylprednisolone, intravenous immunoglobulin, anticoagulants, and mycophenolate mofetil. Oral glucocorticoid was continued with regular monitoring of adrenal function. Mineralocorticoid replacement was not needed as the renin-angiotensin-aldosterone system axis was intact. This report contributes to the sparse literature on catastrophic APS-related BAH, highlighting the need for early diagnosis and combined immunosuppressive and anticoagulant treatment.
SN - 2755-1520
ER -